BANK OF AMERICA CORP /DE/
BankPosition in ACRS — Aclaris Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in ACRS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$298,271
+$104,063 QoQ
Shares Held
79,539
+23.3% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. ACRS ranks #276 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ACRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $298,271 | 79,539 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $194,208 | 64,521 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $142,861 | 75,191 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $103,084 | 72,595 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $256,532 | 167,669 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $509,553 | 205,465 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,070 | 8,757 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,144 | 6,495 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $31,802 | 25,647 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $131,655 | 125,387 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $354,130 | 51,698 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $443,502 | 42,768 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $565,190 | 69,863 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,277,607 | 81,118 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,130,398 | 71,817 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,349,888 | 96,697 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $539,852 | 31,314 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $881,965 | 60,658 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $398,736 | 22,152 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $262,398 | 14,943 | Shares | Defined | 2021-09-13 | |
| 2020-09-30 | $113 | 44 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,108 | 4,388 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $927 | 892 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||